GCS
MRNA icon

Gordian Capital (Singapore)’s Moderna MRNA Stock Holding History

Gordian Capital (Singapore)’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-9
Closed -$354 – 180
2024
Q4 		$354 Hold
9
– – ﹤0.01% 147
2024
Q3 		$601 Hold
9
– – ﹤0.01% 142
2024
Q2 		$1.07K Hold
9
– – ﹤0.01% 126
2024
Q1 		$959 Hold
9
– – ﹤0.01% 78
2023
Q4 		$896 Hold
9
– – ﹤0.01% 69
2023
Q3 		$929 Hold
9
– – ﹤0.01% 65
2023
Q2 		$1.09K Buy
+9
New +$1.2K ﹤0.01% 67

Other funds holding MRNA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Gordian Capital (Singapore)'s MRNA Position: Q1 2025 in Review

Gordian Capital (Singapore) sold out of Moderna (MRNA) in Q1 2025, closing a stake of 9 shares — an estimated $354 sold.

Gordian Capital (Singapore) first reported a position in MRNA in Q2 2023 and held it in 7 quarters. The position peaked at $1.09K in Q2 2023. 694 funds tracked by Wall St. Rank hold MRNA as of Q1 2025.

  • Gordian Capital (Singapore) reported no remaining Moderna position as of Q1 2025 after selling out during the quarter.
  • Gordian Capital (Singapore) sold 9 Moderna shares in Q1 2025, an estimated $354.
  • Gordian Capital (Singapore) first reported a position in Moderna in Q2 2023 and held it in 7 quarters.
  • Gordian Capital (Singapore)'s Moderna position peaked at $1.09K in Q2 2023.
  • 694 funds tracked by Wall St. Rank held Moderna as of Q1 2025.

Based on Gordian Capital (Singapore)'s 13F filing for Q1 2025, filed 15 May 2025.